Crossmark

A randomised controlled, prospective trial protocol comparing MID-MIS approaches for the treatment of discogenic low back pain: clinical outcomes, complication rates, and treatment costs in MIDLIF vs. MIS-TLIF

Crossref DOI link: https://doi.org/10.1186/s12893-026-03779-2

Published Online: 2026-04-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kowal, Aleksander

Krystkiewicz-Orzechowska, Magdalena

Tosik, Marcin

Krystkiewicz, Kamil
License Information

Text and Data Mining valid from 2026-04-28

Accepted Manuscript valid from 2026-04-28
More Information

Article History

Received: 15 October 2025

Accepted: 17 April 2026

First Online: 28 April 2026

Declarations

:

: The study will be conducted in strict accordance with the protocol, the current version of the Declaration of Helsinki, the ICH GCP guidelines, and Polish law. Both the Ethics Committee and the regulatory authority will receive safety reports on an annual and periodic basis during the study.This study has been approved by the Bioethics Committee at the Polish Mother Health Center Institute in Łódź (approval no. 112/2024) on 17 December 2024. Patient recruitment for this study is ongoing; seven patients have been enrolled since January 2025. No sponsor is involved in the study design or conduct.

: Written informed consent was obtained from all participants whose radiological images (X‑rays) were used in this publication for the use of their anonymised imaging data for scientific and publication purposes.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below